(Q54617628)

English

Analysis of tumor burden versus progression-free survival for Phase II decision making.

scientific article

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21266203

retrieved

1 June 2018

reference URL

http://europepmc.org/abstract/MED/21266203

title

Analysis of tumor burden versus progression-free survival for Phase II decision making. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21266203

retrieved

1 June 2018

reference URL

http://europepmc.org/abstract/MED/21266203

1 reference

Jane Fridlyand

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21266203

retrieved

1 June 2018

reference URL

http://europepmc.org/abstract/MED/21266203

Lee D Kaiser

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21266203

retrieved

1 June 2018

reference URL

http://europepmc.org/abstract/MED/21266203

Gwen Fyfe

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21266203

retrieved

1 June 2018

reference URL

http://europepmc.org/abstract/MED/21266203

language of work or name

English

0 references

publication date

23 January 2011

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21266203

retrieved

1 June 2018

reference URL

http://europepmc.org/abstract/MED/21266203

published in

Contemporary Clinical Trials

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21266203

retrieved

1 June 2018

reference URL

http://europepmc.org/abstract/MED/21266203

volume

32

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21266203

retrieved

1 June 2018

reference URL

http://europepmc.org/abstract/MED/21266203

issue

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21266203

retrieved

1 June 2018

reference URL

http://europepmc.org/abstract/MED/21266203

page(s)

446-452

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21266203

retrieved

1 June 2018

reference URL

http://europepmc.org/abstract/MED/21266203

Identifiers

DOI

10.1016/J.CCT.2011.01.010

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21266203

retrieved

1 June 2018

reference URL

http://europepmc.org/abstract/MED/21266203

PubMed publication ID

21266203

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21266203

retrieved

1 June 2018

reference URL

http://europepmc.org/abstract/MED/21266203

(Q54617628)

Analysis of tumor burden versus progression-free survival for Phase II decision making.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)